chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose, Blood glucose increased
Clinical narrative: Increased blood sugar; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (Increased blood sugar) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus since August 2020. Concomitant products included METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE (JANUMET) for Diabetes mellitus, FLUOXETINE and OXCARBAZEPINE for an unknown indication.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced BLOOD GLUCOSE INCREASED (Increased blood sugar). At the time of the report, BLOOD GLUCOSE INCREASED (Increased blood sugar) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Mar-2021, Blood glucose: (High) fluctuating between 170 mg/dL to low 200 mg/dL daily.         Treatment of the events were not reported.Action taken with mRNA-1273 in response to the events was not applicable.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: site of injection is itching; site of injection has red mark (5 inches long); This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (site of injection is itching) and INJECTION SITE ERYTHEMA (site of injection has red mark (5 inches long)) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029KC20A and Unknown) for an unknown indication.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced INJECTION SITE PRURITUS (site of injection is itching) and INJECTION SITE ERYTHEMA (site of injection has red mark (5 inches long)). At the time of the report, INJECTION SITE PRURITUS (site of injection is itching) and INJECTION SITE ERYTHEMA (site of injection has red mark (5 inches long)) had not resolved.            Patient received the treatment drug cortozone-10 cream
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Psoriasis, Vaccination site pruritus
Clinical narrative: Psoriasis; very itchy; This spontaneous case was reported by a consumer and describes the occurrence of PSORIASIS (Psoriasis) and VACCINATION SITE PRURITUS (very itchy) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included AMLODIPINE, BENAZEPRIL, TIMOLOL, ACETYLSALICYLIC ACID (BABY ASPIRIN) and PREDNISONE for an unknown indication.   On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced PSORIASIS (Psoriasis) and VACCINATION SITE PRURITUS (very itchy). On 20-Mar-2021, PSORIASIS (Psoriasis) and VACCINATION SITE PRURITUS (very itchy) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Non significant information provided (Reporter's address).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Head discomfort, Nausea, Vision blurred
Clinical narrative: Blurry vision; Loss of balance; Dizziness; Strange feeling of pressure in the head; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Blurry vision), BALANCE DISORDER (Loss of balance), DIZZINESS (Dizziness), HEAD DISCOMFORT (Strange feeling of pressure in the head) and NAUSEA (Nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was provided.).    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced VISION BLURRED (Blurry vision), BALANCE DISORDER (Loss of balance), DIZZINESS (Dizziness), HEAD DISCOMFORT (Strange feeling of pressure in the head) and NAUSEA (Nausea). The patient was treated with MECLIZINE [MECLOZINE] at a dose of 1 dosage form. At the time of the report, VISION BLURRED (Blurry vision), BALANCE DISORDER (Loss of balance), DIZZINESS (Dizziness), HEAD DISCOMFORT (Strange feeling of pressure in the head) and NAUSEA (Nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Feeling abnormal, Headache, Oropharyngeal pain, SARS-CoV-2 test
Clinical narrative: Covid 19 diagnosis after first dose; headache; sore throat; feeling really bad; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), FEELING ABNORMAL (feeling really bad), COVID-19 (Covid 19 diagnosis after first dose) and HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), FEELING ABNORMAL (feeling really bad) and HEADACHE (headache). On an unknown date, the patient experienced COVID-19 (Covid 19 diagnosis after first dose). At the time of the report, OROPHARYNGEAL PAIN (sore throat), FEELING ABNORMAL (feeling really bad), COVID-19 (Covid 19 diagnosis after first dose) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) COVID-19 Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessment.  No concomitant medications were reported. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient hasn't received 2nd dose yet and it's been past 42 days; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient hasn't received 2nd dose yet and it's been past 42 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milligram. On 23-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient hasn't received 2nd dose yet and it's been past 42 days). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient hasn't received 2nd dose yet and it's been past 42 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was not reported. No treatment medication was not reported  Action taken with mRNA-1273 in response to the event was unknown   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Patient stated  that she did not experienced an adverse events from the vaccine.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Red circle around injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red circle around injection site) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No medical history was reported.     On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red circle around injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Red circle around injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant  information was  provided. No Treatment information was  provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, COVID-19 immunisation, Lethargy, Swelling face
Clinical narrative: swelling on face; joint paint; Feels lethargic; Hasn't been able to exercise; has not received 2nd dose; pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at injection site), SWELLING FACE (swelling on face), ARTHRALGIA (joint paint), LETHARGY (Feels lethargic) and ASTHENIA (Hasn't been able to exercise) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE PAIN (pain at injection site). On 28-Feb-2021, the patient experienced SWELLING FACE (swelling on face), ARTHRALGIA (joint paint), LETHARGY (Feels lethargic), ASTHENIA (Hasn't been able to exercise) and COVID-19 IMMUNISATION (has not received 2nd dose). At the time of the report, VACCINATION SITE PAIN (pain at injection site), SWELLING FACE (swelling on face), ARTHRALGIA (joint paint), LETHARGY (Feels lethargic), ASTHENIA (Hasn't been able to exercise) and COVID-19 IMMUNISATION (has not received 2nd dose) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant Medication was available. No Treatments Medication was available.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: swelling on face; joint paint; Feels lethargic; Hasn't been able to exercise; has not received 2nd dose; pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at injection site), SWELLING FACE (swelling on face), ARTHRALGIA (joint paint), LETHARGY (Feels lethargic) and ASTHENIA (Hasn't been able to exercise) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE PAIN (pain at injection site). On 28-Feb-2021, the patient experienced SWELLING FACE (swelling on face), ARTHRALGIA (joint paint), LETHARGY (Feels lethargic), ASTHENIA (Hasn't been able to exercise) and COVID-19 IMMUNISATION (has not received 2nd dose). At the time of the report, VACCINATION SITE PAIN (pain at injection site), SWELLING FACE (swelling on face), ARTHRALGIA (joint paint), LETHARGY (Feels lethargic), ASTHENIA (Hasn't been able to exercise) and COVID-19 IMMUNISATION (has not received 2nd dose) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant Medication was available. No Treatments Medication was available.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: pain in the left arm; pain always down to the elbow; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the left arm) and ARTHRALGIA (pain always down to the elbow) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced PAIN IN EXTREMITY (pain in the left arm) and ARTHRALGIA (pain always down to the elbow). The patient was treated with PREDNISONE at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (pain in the left arm) and ARTHRALGIA (pain always down to the elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Device connection issue, Incorrect dose administered, Incorrect dose administered by device, Underdose
Clinical narrative: Vaccine leaked while administering; vaccine began to leak out around the hub of the needle; Patient was then given the missed 0.2ml of the Moderna vaccine in the left deltoid muscle; patient had received less than half of the recommended dose; This spontaneous case was reported by a nurse and describes the occurrence of INCORRECT DOSE ADMINISTERED BY DEVICE (Vaccine leaked while administering), DEVICE CONNECTION ISSUE (vaccine began to leak out around the hub of the needle), INCORRECT DOSE ADMINISTERED (Patient was then given the missed 0.2ml of the Moderna vaccine in the left deltoid muscle) and UNDERDOSE (patient had received less than half of the recommended dose) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced INCORRECT DOSE ADMINISTERED BY DEVICE (Vaccine leaked while administering), DEVICE CONNECTION ISSUE (vaccine began to leak out around the hub of the needle), INCORRECT DOSE ADMINISTERED (Patient was then given the missed 0.2ml of the Moderna vaccine in the left deltoid muscle) and UNDERDOSE (patient had received less than half of the recommended dose). On 25-Mar-2021, INCORRECT DOSE ADMINISTERED BY DEVICE (Vaccine leaked while administering), DEVICE CONNECTION ISSUE (vaccine began to leak out around the hub of the needle), INCORRECT DOSE ADMINISTERED (Patient was then given the missed 0.2ml of the Moderna vaccine in the left deltoid muscle) and UNDERDOSE (patient had received less than half of the recommended dose) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Apr-2021: The patient information and event details were updated.; Sender's Comments: This report refers to a case of incorrect dose administered for mRNA-1273 with no associated AEs.
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: Has not been feeling good; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Has not been feeling good) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Has not been feeling good). At the time of the report, FEELING ABNORMAL (Has not been feeling good) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pruritus
Clinical narrative: arm has been itchy n the area where she received the vaccine; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE PRURITUS (arm has been itchy n the area where she received the vaccine) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     Concomitant products included EZETIMIBE for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 24-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (arm has been itchy n the area where she received the vaccine). At the time of the report, PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE PRURITUS (arm has been itchy n the area where she received the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information were not provided.   Reporter did not allow further contact
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Injection site pain
Clinical narrative: Injection site pain; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Injection site pain), CHILLS ( chills) and HEADACHE (headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     Concurrent medical conditions included Osteoarthritis. Concomitant products included VITAMIN D [VITAMIN D NOS] for Osteoarthritis, LEVOTHYROXINE SODIUM (SYNTHYROID) for an unknown indication.    On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced INJECTION SITE PAIN (Injection site pain), CHILLS ( chills) and HEADACHE (headache). At the time of the report, INJECTION SITE PAIN (Injection site pain), CHILLS ( chills) and HEADACHE (headache) outcome was unknown.            No treatment medication were provided. Action taken for Moderna  COVID-19 Vaccine was not applicable.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Pain in extremity, Paraesthesia, Presyncope, Tachycardia
Clinical narrative: maybe it was vasovagal episode; tingling all over; arm was sore; dizziness gotten worse; tachycardia right after vaccine about 10 minutes after; This spontaneous case was reported by a physician and describes the occurrence of TACHYCARDIA (tachycardia right after vaccine about 10 minutes after), PRESYNCOPE (maybe it was vasovagal episode), PARAESTHESIA (tingling all over), PAIN IN EXTREMITY (arm was sore) and DIZZINESS (dizziness gotten worse) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced TACHYCARDIA (tachycardia right after vaccine about 10 minutes after). On an unknown date, the patient experienced PRESYNCOPE (maybe it was vasovagal episode), PARAESTHESIA (tingling all over), PAIN IN EXTREMITY (arm was sore) and DIZZINESS (dizziness gotten worse). The patient was treated with MOMETASONE FUROATE (NASONEX) at an unspecified dose and frequency. At the time of the report, TACHYCARDIA (tachycardia right after vaccine about 10 minutes after), PRESYNCOPE (maybe it was vasovagal episode), PARAESTHESIA (tingling all over), PAIN IN EXTREMITY (arm was sore) and DIZZINESS (dizziness gotten worse) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.
Sex: U
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of increased heart rate  (rapid heartbeat) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced increased heart rate (rapid heartbeat). At the time of the report, increased heart rate (rapid heartbeat) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information reported.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Product administered to patient of inappropriate age
Clinical narrative: Fatigued; 15 years old received the 1st dose of Moderna vaccine; Headaches; A spontaneous report was received from a caregiver, concerning a 15-year-old female patient, who received Moderna's COVID-19 vaccine (Product administered to patient of inappropriate age) and experienced headaches (Headache) and was fatigued (fatigue).  The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, included fluoxetine hydrochloride, oxymetazoline hydrochloride, cetirizine hydrochloride, Hycosamine.  On 23 Mar 2021, prior to the onset of events, the patient received her first of the two planned vaccine doses of mRNA-1273 (lot number 007B21A) via intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 24 Mar 2021, after receiving the first dose, patient was fatigued.   On 25 Mar 2021, she experienced headaches. Treatment medication included paracetamol.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the event, 15 year old received the 1st dose of Moderna vaccine was considered to be resolved on 23 Mar 2021 and outcome of fatigued and headaches, was unknown at the time of this report.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, Headache and Fatigue, a causal relationship cannot be excluded. This report also refers to a case of Product administered to patient of inappropriate age, for mRNA-1273, lot #: 007B21A.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, Vaccination site pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of rhinorrhea (runny nose) and vaccination site pain (pain around the injection site for three days) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 032MIVA) for COVID-19 vaccination. No reported medical history. On Mar 17, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 20, 2021, patient experienced rhinorrhea (runny nose). On an unknown date, patient experienced vaccination site pain (pain around the injection site for three days). On Mar 25, 2021, vaccination site pain (pain around the injection site for three days) resolved. At the time of the report, rhinorrhea (runny nose): resolving. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication reported.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea
Clinical narrative: headache; Fatigue; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), FATIGUE (Fatigue) and NAUSEA (Nausea) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included OMEPRAZOLE for an unknown indication.   On 20-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 20-Mar-2021, the patient experienced HEADACHE (headache), FATIGUE (Fatigue) and NAUSEA (Nausea). At the time of the report, HEADACHE (headache), FATIGUE (Fatigue) and NAUSEA (Nausea) outcome was unknown.        Patient wanted to know if it was true that if someone does not have side effects from Moderna vaccine that person will not be protected against the virus (read that in social networks). Patient thinks that symptoms are due to not sleeping well night before getting the vaccine.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Eye irritation, Lacrimation increased, Ocular hyperaemia, Rhinorrhoea
Clinical narrative: watering nose; tearing eyes; burning eyes; red eye; A spontaneous report was received from a consumer concerning a patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events watering nose, tearing eyes, burning eyes, red eye.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 038A21A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 24 Mar 2021, the patient experienced the event(s) watering nose, tearing eyes, burning eyes, red eye.  Treatment details included Visine.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), watering nose, tearing eyes, burning eyes, red eye was unknown.
Age: 58.0
Sex: U
Vaccine: COVID19
Symptoms: Dehydration, Headache, Nausea, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DEHYDRATION (Very dehydrated), HEADACHE (Bad headache for a week), PYREXIA (Fever of 102°F for a week) and NAUSEA (Sick to their stomach and wanting to throw up) in a 58-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 05-Mar-2021 at 3:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced DEHYDRATION (Very dehydrated), HEADACHE (Bad headache for a week) and PYREXIA (Fever of 102°F for a week). On an unknown date, the patient experienced NAUSEA (Sick to their stomach and wanting to throw up). At the time of the report, DEHYDRATION (Very dehydrated), HEADACHE (Bad headache for a week), PYREXIA (Fever of 102°F for a week) and NAUSEA (Sick to their stomach and wanting to throw up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  No treatment information was provided.    This case was linked to MOD-2021-040770 (Patient Link).
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nausea
Clinical narrative: She experienced very bad headache; Nauseated; Muscle ache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (She experienced very bad headache), NAUSEA (Nauseated) and MYALGIA (Muscle ache) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced HEADACHE (She experienced very bad headache), NAUSEA (Nauseated) and MYALGIA (Muscle ache). At the time of the report, HEADACHE (She experienced very bad headache), NAUSEA (Nauseated) and MYALGIA (Muscle ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Paraesthesia, Peripheral swelling, Urticaria
Clinical narrative: their left arm was swelling; had a small hive on the right arm; headache; felt a tingling sensation on their face like they just had a shot of alcohol; This spontaneous case was reported by a health care professional and describes the occurrence of PARAESTHESIA (felt a tingling sensation on their face like they just had a shot of alcohol), PERIPHERAL SWELLING (their left arm was swelling), URTICARIA (had a small hive on the right arm) and HEADACHE (headache) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced PARAESTHESIA (felt a tingling sensation on their face like they just had a shot of alcohol). On 20-Mar-2021, the patient experienced PERIPHERAL SWELLING (their left arm was swelling), URTICARIA (had a small hive on the right arm) and HEADACHE (headache). The patient was treated with ACETAMINOPHEN ongoing since an unknown date for Symptomatic treatment, at an unspecified dose and frequency. On 20-Mar-2021, PARAESTHESIA (felt a tingling sensation on their face like they just had a shot of alcohol), PERIPHERAL SWELLING (their left arm was swelling), URTICARIA (had a small hive on the right arm) and HEADACHE (headache) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain in extremity, Tremor, Vertigo
Clinical narrative: soreness; Couldnot stop shaking the night; rotatory vertigo; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness), TREMOR (Couldnot stop shaking the night), VERTIGO (rotatory vertigo) and CHILLS (chills) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included ESTRADIOL (ESTRADIOL TRANSDERMAL) for an unknown indication.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (soreness), TREMOR (Couldnot stop shaking the night), VERTIGO (rotatory vertigo) and CHILLS (chills). On 11-Mar-2021, VERTIGO (rotatory vertigo) outcome was unknown. At the time of the report, PAIN IN EXTREMITY (soreness), TREMOR (Couldnot stop shaking the night) and CHILLS (chills) outcome was unknown.            Treatment information was not provided   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: follow-up received no new information On 22-Jul-2021: Follow-up received and contains non-significant information
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Limb discomfort, Pain, Pain in extremity
Clinical narrative: cannot raise arm; itching; sore arm; aches everywhere; bad headache; fever over 101°F; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (cannot raise arm), PRURITUS (itching), PAIN IN EXTREMITY (sore arm), PAIN (aches everywhere) and HEADACHE (bad headache) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced LIMB DISCOMFORT (cannot raise arm), PRURITUS (itching), PAIN IN EXTREMITY (sore arm), PAIN (aches everywhere), HEADACHE (bad headache) and PYREXIA (fever over 101°F). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, LIMB DISCOMFORT (cannot raise arm), PRURITUS (itching), PAIN IN EXTREMITY (sore arm), PAIN (aches everywhere), HEADACHE (bad headache) and PYREXIA (fever over 101°F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) 101°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included birth control pill.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia
Clinical narrative: cannot raise arm; itching; sore arm; aches everywhere; bad headache; fever over 101°F; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (cannot raise arm), PRURITUS (itching), PAIN IN EXTREMITY (sore arm), PAIN (aches everywhere) and HEADACHE (bad headache) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced LIMB DISCOMFORT (cannot raise arm), PRURITUS (itching), PAIN IN EXTREMITY (sore arm), PAIN (aches everywhere), HEADACHE (bad headache) and PYREXIA (fever over 101°F). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, LIMB DISCOMFORT (cannot raise arm), PRURITUS (itching), PAIN IN EXTREMITY (sore arm), PAIN (aches everywhere), HEADACHE (bad headache) and PYREXIA (fever over 101°F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) 101°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included birth control pill.
Age: 70.0
Sex: U
Vaccine: COVID19
Symptoms: Back pain, Headache, Nausea
Clinical narrative: back pain; little sick in her stomach; headaches in the front of her head; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back pain), NAUSEA (little sick in her stomach) and HEADACHE (headaches in the front of her head) in a 70-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 039A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BACK PAIN (back pain), NAUSEA (little sick in her stomach) and HEADACHE (headaches in the front of her head). The patient was treated with PARACETAMOL (TYLENOL) for Headache and Back ache, at an unspecified dose and frequency. At the time of the report, BACK PAIN (back pain), NAUSEA (little sick in her stomach) and HEADACHE (headaches in the front of her head) outcome was unknown. Not Provided          No relevant concomitant medications were reported.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chest pain, Headache, Influenza like illness, Insomnia
Clinical narrative: patient experienced sore arm; hotness; pressure in the head (also said headache) at night; back ache; chest aches; flu-like; could not sleep; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (patient experienced sore arm), VACCINATION SITE WARMTH (hotness), HEADACHE (pressure in the head (also said headache) at night), BACK PAIN (back ache) and CHEST PAIN (chest aches) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE PAIN (patient experienced sore arm), VACCINATION SITE WARMTH (hotness), HEADACHE (pressure in the head (also said headache) at night), BACK PAIN (back ache), CHEST PAIN (chest aches), INFLUENZA LIKE ILLNESS (flu-like) and INSOMNIA (could not sleep). On 19-Mar-2021, VACCINATION SITE PAIN (patient experienced sore arm) had resolved. On 21-Mar-2021, VACCINATION SITE WARMTH (hotness), HEADACHE (pressure in the head (also said headache) at night), BACK PAIN (back ache), CHEST PAIN (chest aches), INFLUENZA LIKE ILLNESS (flu-like) and INSOMNIA (could not sleep) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications of the patient included Naproxen and Tylenol. No concomitant medications of the patient were provided.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site warmth
Clinical narrative: patient experienced sore arm; hotness; pressure in the head (also said headache) at night; back ache; chest aches; flu-like; could not sleep; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (patient experienced sore arm), VACCINATION SITE WARMTH (hotness), HEADACHE (pressure in the head (also said headache) at night), BACK PAIN (back ache) and CHEST PAIN (chest aches) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE PAIN (patient experienced sore arm), VACCINATION SITE WARMTH (hotness), HEADACHE (pressure in the head (also said headache) at night), BACK PAIN (back ache), CHEST PAIN (chest aches), INFLUENZA LIKE ILLNESS (flu-like) and INSOMNIA (could not sleep). On 19-Mar-2021, VACCINATION SITE PAIN (patient experienced sore arm) had resolved. On 21-Mar-2021, VACCINATION SITE WARMTH (hotness), HEADACHE (pressure in the head (also said headache) at night), BACK PAIN (back ache), CHEST PAIN (chest aches), INFLUENZA LIKE ILLNESS (flu-like) and INSOMNIA (could not sleep) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications of the patient included Naproxen and Tylenol. No concomitant medications of the patient were provided.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Administered dose to 17 years old 2 male patients; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administered dose to 17 years old 2 male patients) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administered dose to 17 years old 2 male patients). On 16-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administered dose to 17 years old 2 male patients) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment was reported.   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Followup email received on 04-JUN-2021 contains no new information; Sender's Comments: This report refers to a case of product administered to patient of inappropriate age (17 year old male) for mRNA-1273 (lot number unknown) with no associated AEs reported.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Limb discomfort, Pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain for the first couple of days) and LIMB DISCOMFORT (Light discomfort in his upper arm that comes and goes) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN (Pain for the first couple of days) and LIMB DISCOMFORT (Light discomfort in his upper arm that comes and goes). The patient was treated with IBUPROFEN at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, PAIN (Pain for the first couple of days) and LIMB DISCOMFORT (Light discomfort in his upper arm that comes and goes) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Other treatment information included application of Ice.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) outcome was unknown.            No concomitant medication iwere not provided No treatment medication information were not provided.  Action taken with mRNA-1273 in response to the event was not applicable.   Reporter did not allow further contact
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Weird rash on the left arm, not on the injection site.; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Weird rash on the left arm, not on the injection site.) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Weird rash on the left arm, not on the injection site.). The patient was treated with PARACETAMOL (TYLENOL) for Paracetamol, at an unspecified dose and frequency. At the time of the report, RASH (Weird rash on the left arm, not on the injection site.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported.    Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: No specific follow-up information recorded.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effects) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects). At the time of the report, VACCINATION COMPLICATION (side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant product usage were not reported by the reporter. No treatment details were added. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Cardiac discomfort, Discomfort, Headache, Influenza like illness
Clinical narrative: flu like symptoms; upset stomach; had pressure in her heart; was feeling uncomfortable; fever; body pains; headache; redness injection down to the elbow; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-Mar-2021 and was forwarded to Moderna on 25-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), ABDOMINAL DISCOMFORT (upset stomach), CARDIAC DISCOMFORT (had pressure in her heart), DISCOMFORT (was feeling uncomfortable) and PYREXIA (fever) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hyperacidity (Acidy stomach). Concurrent medical conditions included Heart disorder, Latex allergy, Fruit allergy (Apples), Shellfish allergy, Broken heart syndrome, Diabetes, Hypertension, Rheumatoid arthritis, Osteoporosis, Fibromyalgia, Asthma and Diverticulitis. Concomitant products included IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE (COMBIVENT), ALBUTEROL SULFATE, METFORMIN, EMPAGLIFLOZIN (JARDIANCE), METHOTREXATE, MONTELUKAST, EZETIMIBE, ATORVASTATIN, VITAMIN D2, METOPROLOL, FAMOTIDINE, ASPIRIN [ACETYLSALICYLIC ACID], FOLIC ACID, GABAPENTIN, TRAMADOL, METHYLPREDNISOLONE, AMITRIPTYLINE, LOSARTAN and ZOLPIDEM TARTRATE (AMBIEN) for an unknown indication.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), ABDOMINAL DISCOMFORT (upset stomach), CARDIAC DISCOMFORT (had pressure in her heart), DISCOMFORT (was feeling uncomfortable), PYREXIA (fever), MYALGIA (body pains), HEADACHE (headache) and VACCINATION SITE ERYTHEMA (redness injection down to the elbow). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), ABDOMINAL DISCOMFORT (upset stomach), CARDIAC DISCOMFORT (had pressure in her heart), DISCOMFORT (was feeling uncomfortable), HEADACHE (headache) and VACCINATION SITE ERYTHEMA (redness injection down to the elbow) had resolved and PYREXIA (fever) and MYALGIA (body pains) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment details were reported.